Get Skinny
The leadSemaglutide, body contouring, and medically-supervised programs

The full file

Everything we have reported

46 stories

Pulling the next stories

Common questions

What readers
ask us.

  • GLP-1 receptor agonists (semaglutide, tirzepatide) mimic gut hormones that signal satiety, slow gastric emptying, and modulate insulin response. Patients typically experience reduced appetite and food noise. Published trials show 15-20%+ body weight loss with sustained use.

The Briefing

The latest, in your inbox.

A short, occasional dispatch on medically supervised weight solutions, new research, treatment advances, and the stories worth your time. No spam, unsubscribe anytime.

We send rarely and never sell your information.